181 related articles for article (PubMed ID: 10897662)
1. [Mechanism of progression of chronic renal failure and new treatment strategies].
Litwin M
Pol Merkur Lekarski; 2000 Apr; 8(46):301-2. PubMed ID: 10897662
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor selectivity in chronic renal failure.
Longaretti L; Benigni A
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():32-7. PubMed ID: 19335745
[TBL] [Abstract][Full Text] [Related]
3. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
4. [Renoprotective effects of antihypertensives].
Monhart V
Vnitr Lek; 2004 Jul; 50(7):531-6. PubMed ID: 15323261
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
6. Requirement of drug development for chronic renal disease: Other strategies than blockade of the renin-angiotensin system.
Okamoto T
Int J Mol Med; 2003 May; 11(5):651-4. PubMed ID: 12684706
[TBL] [Abstract][Full Text] [Related]
7. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
Ferrari P
Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 in chronic renal failure and hypertension.
Larivière R; Lebel M
Can J Physiol Pharmacol; 2003 Jun; 81(6):607-21. PubMed ID: 12839272
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
Maione A; Strippoli GF
Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
[TBL] [Abstract][Full Text] [Related]
10. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
11. Progression to renal failure.
Topaloğlu R
Turk J Pediatr; 2005; 47 Suppl():3-8. PubMed ID: 15884660
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease.
Myers BD; Boothroyd D; Olshen RA
J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S66-70. PubMed ID: 11443771
[TBL] [Abstract][Full Text] [Related]
13. Reversal of proteinuric renal disease and the emerging role of endothelin.
Barton M
Nat Clin Pract Nephrol; 2008 Sep; 4(9):490-501. PubMed ID: 18648345
[TBL] [Abstract][Full Text] [Related]
14. [Progressive renal failure. Why blood pressure must now be monitored].
Tepel M; van der Giet M; Zidek W
MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
Bakris GL; Weir MR
Postgrad Med; 2008 Apr; 120(1):33-42. PubMed ID: 18467807
[TBL] [Abstract][Full Text] [Related]
16. Can we slow the progression of chronic kidney disease?
Wühl E; Schaefer F
Curr Opin Pediatr; 2010 Apr; 22(2):170-5. PubMed ID: 20042976
[TBL] [Abstract][Full Text] [Related]
17. The progression of chronic renal disease: immunological, nutritional and intrinsic renal mechanisms.
Drukker A
Isr J Med Sci; 1997 Nov; 33(11):739-43. PubMed ID: 9434811
[TBL] [Abstract][Full Text] [Related]
18. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
Tesar V
Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
[TBL] [Abstract][Full Text] [Related]
19. The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failure.
Barnas U; Schmidt A; Haas M; Oberbauer R; Mayer G
Nephrol Dial Transplant; 1996 Sep; 11(9):1822-4. PubMed ID: 8918629
[No Abstract] [Full Text] [Related]
20. The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease.
Norris K; Vaughn C
Expert Rev Cardiovasc Ther; 2003 May; 1(1):51-63. PubMed ID: 15030297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
